Eupraxia Pharmaceuticals (EPRX) Debt Ratio (2022 - 2024)

Eupraxia Pharmaceuticals (EPRX) has 3 years of Debt Ratio data on file, last reported at 0.0 in Q2 2024.

• On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.0 in Q2 2024; TTM through Jun 2024 was 0.0, a N/A change from a year earlier, with the FY2023 full-year figure at 0.51, up 6803.49% from the prior year.
• Debt Ratio for Q2 2024 stood at 0.0, down from 0.0 in the prior quarter.
• Over the last five years, Debt Ratio for EPRX reached as high as 0.51 in Q4 2023 and fell as low as 0.0 in Q2 2024.
• Historically, Debt Ratio has averaged 0.13 across 3 years, with a median of 0.0 in 2022.
• On a YoY basis, Debt Ratio climbed as much as 6803.49% in 2023 and fell as far as 6803.49% in 2023.
• Year by year, Debt Ratio stood at 0.01 in 2022, then soared by 6803.49% to 0.51 in 2023, then sank by 99.83% to 0.0 in 2024.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.0 in Q2 2024, 0.0 in Q1 2024, and 0.51 in Q4 2023.